Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Utilize a multidisciplinary structural heart team approach to diagnose and treat structural heart disease.
• Recognize the echocardiographic presentation and application of advanced imaging in patients with valvular heart disease and atrial fibrillation, including hypertrophic cardiomyopathy.
• Demonstrate the utility of multimodality imaging in hypertrophic cardiomyopathy, and workup for left atrial appendage and in valvular heart disease.
• Assess and apply a comprehensive approach when managing the aortic, mitral and tricuspid valves and the interatrial septum, utilizing basic and advanced imaging techniques to identify and guide the treatment of valvular heart disease.
• Utilize current evidence-based clinical data in TAVR, TMVR, TEER, LAA occluder devices, paravalvular leak and alcohol septal ablation to optimize treatment.
• Demonstrate the management and utility of transesophageal and 3-D imaging in the cardiac catheterization lab to guide structural heart procedures.
• Further define the tricuspid valve anatomy and function and describe the implications for treatment of tricuspid regurgitation using transcatheter therapy.
• Avoid common pitfalls in imaging patients in cardio-oncology, hypertrophic cardiomyopathy and structural heart disease.
• Define protocols that can assess valvular heart disease after intervention.

Who Should Attend

Cardiologists, cardiac surgeons, vascular surgeons, internists, intensivists, interventional radiologists, anesthesiologists, emergency medicine physicians, critical care physicians, fellows, echocardiography and noninvasive vascular testing specialists, sonographers, nurses, nurse practitioners, physician assistants, pharmacists, respiratory therapists, and medical professionals interested in echocardiography and the newest advances in diagnosis and treatment of structural heart disease.